TrIE aim of the present study was to investigate the possible effect of platelet-activating factor (PAF), by comparison with interleukin-l and polyriboinositic/ polyribocytidylic (poly I--C) acid, on 11-6 production by L 929 mouse flbroblasts. At concentrations above 1 gtM PAF, the production of 11-6 by mouse flbroblasts was enhanced in a dose dependent fashion. At 5 tM PAF, the peak increase (60.1 + 19.4 U/ml) was similar to that induced by 50 tg/ml poly I--C (60.0 + 35.0 U/ml) and higher than the one evoked by 100 U/ml U/ml). The increase of 11-6 activity induced by 5 tM PAF was maximal after a 22 h incubation period with L 929 cells. Lyso-PAF (5 ttM) also increased 11-6 activity from flbroblasts to a similar extent compared with 5 tM PAF. In addition, the 11-6 activity induced by 5 tM PAF was still observed when the specific PAF antagonist, BN 52021 (10 ttM), was added to the incubation medium of L 929 cells. The result suggests that the production of 11-6 by L 929 cells evoked by PAF in vitro is not receptor mediated. The in vivo effect of PAF on 11-6 production was also investigated in the rat. Two hours after intravenous injection of PAF (2 to 4 tg/kg), a dramatic increase of 11-6 activity in rat serum was observed, this effect being dose dependent. 
Introduction
A T cell line derived, B cell differentiation factor (B cell stimulatory factor-2) has been identified in both human and mouse. This protein has been shown to be identical to fibroblast derived interferon-[,. (IFN- [2) 3,4 and has been referred to as interleukin-6 (IL-6). This cytokine is produced by a wide variety of cell types and demonstrates many biological effects, both in vitro and in vivo. Although its primary source appears to be the monocyte/macrophage, 7, 8 It has been demonstrated previously that the phospholipid mediator, PAF modulates the production of the monocyte/macrophage derived cytokine, IL-1, both in vitro 4 and in vivo. 5 Indeed, this lipid mediator either increases or decreases IL-1 activity in cell supernatants from. lipopolysaccharide (LPS) stimulated rat macrophages according to the dose and the time period of addition. As accessory cells produce both IL-11 and IL-6, the question arose whether PAF could also modulate the in vitro and in vivo production of IL-6.
Materials and Methods
Reagents: The double-stranded RNA, polyriboinosinic/polyribocytidylic (poly I-C) and bovine serum albumin (BSA) were (Fig. 3) .
Addition of the anti-IL-6 antibody to supernatants from unstimulated and PAF stimulated L 929 cells inhibited by 84 to 90% the proliferation of 7TD1 cells (Fig. 3) Effect of PAF on IL-6 levels in rat serum: Intravenous injection of lyso-PAF at 2 and 3 l.tg/kg did not modify the level of IL-6 in rat serum after 1 h to 24 h (Fig.  4) . In contrast, the IL-6 level was markedly increased in a dose dependent fashion when rats were treated with PAF at doses ranging from 2 to 4 l.tg/kg and with a peak effect observed 2 h after injection (Fig. 4) Fig. 6 , no IL-6 activity in serum was detected at all time points of this kinetic study.
Discussion
In the present study, it is confirmed that the fibroblast cell line, L 929, produces IL-6-1ike activity and that this production is enhanced by IL-I and to a greater extent by poly I-C, PAF and lyso-PAF. IL-lJ is already known as one of the physiologic inducers of IL-6 by fibroblasts. The double-stranded RNA, poly I-C, has also been shown to induce IL-6, 
